Modification of antimicrobial peptide with low molar mass poly(ethylene glycol)

Journal of Biochemistry

Volumn 144, Issue 6, 2008, Pages 781-788

  Zhang, Genghui ^a   Han, Baozhong ^a   Lin, Xiaoyan ^a   Wu, Xin ^a   Yan, Husheng ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Antimicrobial peptides; Micelles; PEGylation; Peptides; Self assembly

Indexed keywords

CHYMOTRYPSIN; GLYCYLLEUCYLLEUCYLALANYLLEUCYLISOLEUCYLLEUCYLTRYPTOPHYLISOLEUCYLLYSYL ARGINYLLYSYLARGININE AMIDE; MACROGOL; MONOMETHOXY MACROGOL 1100 GLYCYLLEUCYLLEUCYLALANYLLEUCYLISOLEUCYLLEUCYLTRYPTOPHYLISOLEUCYLLYSYL ARGINYLLYSYLARGININE AMIDE; MONOMETHOXY MACROGOL 750 GLYCYLLEUCYLLEUCYLALANYLLEUCYLISOLEUCYLLEUCYLTRYPTOPHYLISOLEUCYLLYSYL ARGINYLLYSYLARGININE AMIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; AQUEOUS SOLUTION; ARTICLE; BACILLUS SUBTILIS; CHEMICAL MODIFICATION; CYTOTOXICITY; DRUG DEGRADATION; ESCHERICHIA COLI; EX VIVO STUDY; HEMOLYSIS; HUMAN; HUMAN CELL; HYDROPHOBICITY; IN VITRO STUDY; MICELLE; MOLECULAR MODEL; MOLECULAR WEIGHT; NONHUMAN; PROTEIN ASSEMBLY; STAPHYLOCOCCUS AUREUS;

ANTIMICROBIAL CATIONIC PEPTIDES; CIRCULAR DICHROISM; DRUG CARRIERS; HYDROPHOBICITY; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR WEIGHT; POLYETHYLENE GLYCOLS;

EID: 57749180588     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvn134     Document Type: Article

References (40)

1. Lee, V.H.L. (1991) Peptide and Protein Drug Delivery. Mercel Dekker, New York
2. Marx, V. (2005) Watching peptide drugs grow up. Chem. Eng. News 83, 17-24
3. Lien, S. and Lowman, H.B. (2003) Therapeutic peptides. Trends Biotechnol. 21, 556-562
4. Harris, J.M. and Chess, R.B. (2003) Effect of PEGylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214-221
5. Sato, A.K., Viswanathan, M., Kent, R.B., and Wood, C.R. (2006) Therapeutic peptides: technological advances driving peptides into development. Curr. Opin. Biotechnol. 17, 638-642
6. Roberts, M.J., Bentley, M.D., and Harris, J.M. (2002) Chemistry for peptide and protein PEGylation. Adv. Drug Deliv. Rev. 54, 459-476
7. Pasut, G. and Veronese, F.M. (2007) Polymer-drug conjugation, recent achievements and general strategies. Prog. Polym. Sci. 32, 933-961
8. Syed, S., Schuyler, P.D., Kulczycky, M., and Sheffield, W.P. (1997) Potent antithrombin activity and delayed clearance from the circulation characterize recombinant hirudin genetically fused to albumin. Blood 89, 3243-3252
9. Dennis, M.S., Zhang, M., Meng, Y.G., Kadkhodayan, M., Kirchhofer, D., Combs, D., and Damico, L.A. (2002) Albumin binding as a general strategy for improving the pharmacokinetics of proteins. J. Biol. Chem. 277, 35035-35043
10. Meyer, J., Whitcomb, L., and Collins, D. (1994) Efficient encapsulation of proteins within liposomes for slow release in vivo. Biochem. Biophys. Res. Commun. 199, 433-438
11. Esposito, P., Barbero, L., Caccia, P., Caliceti, P., D'Antonio, M., Piquet, G., and Veronese, F.M. (2003) PEGylation of growth hormone-releasing hormone (GRF) analogues. Adv. Drug Deliv. Rev. 55, 1279-1291
12. Bowen, S., Bowen, S., Tare, N., Yamasaki, M., Okabe, M., Horii, I., and Eliason, J.F. (1999) Relationship between molecular mass and duration of activity of polyethylene glycol conjugated granulocyte colony-stimulating factor mutein. Exp. Hematol. 27, 425-432
13. Bailon, P., Palleroni, A., Schaffer, C.A., Spence, C.L., Fung, W.-J., Porter, J.E., Ehrlich, G.K., Pan, W., Xu, Z.-X., Modi, M.W., Farid, A., Berthold, W., and Graves, M. (2001) Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon-alpha 2a for the treatment of hepatitis C. Bioconjug. Chem. 12, 195-202
14. Youn, Y.S., Na, D.H., and Lee, K.C. (2007) High-yield production of biologically active mono-PEGylated salmon calcitonin by site-specific PEGylation. J. Control. Release 117, 371-379
15. Imura, Y., Nishida, M., Ogawa, Y., Takakura, Y., and Matsuzaki, K. (2007) Action mechanism of tachyplesin I and effects of PEGylation. Biochim. Biophys. Acta 1768, 1160-1169
16. Lumb, K.J., DeCarr, L.B., Lucinda, F.M., Mays, M.R., Buckholz, T.M., Fisk, S.E., Pellegrino, C.M., Ortiz, A.A., and Mahle, C.D. (2007) Novel selective neuropeptide Y2 receptor PEGylated peptide agonists reduce food intake and body weight in mice. J. Med. Chem. 50, 2264-2268
17. Guiotto, A., Pozzobon, M., Canevari, M., Manganelli, R., Scarin, M., and Veronese, F.M. (2003) PEGylation of the antimicrobial peptide nisin A: problems and perspectives. Il Farmaco 58, 45-50
18. Mammen, M., Shakhnovich, E.I., Deutch, J.M., and Whitesides, G.M. (1998) Estimating the entropic cost of self-assembly of multiparticle hydrogen-bonded aggregates based on the cyanuric acid-melamine lattice. J. Org. Chem. 63, 3821-3830
19. Zhang, L. and Falla, T.J. (2006) Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. 7, 653-663
20. Zasloff, M. (2002) Antimicrobial peptides of multicellular organisms. Nature 415, 389-395
21. Wade, D., Boman, A., Wahlin, B., Drain, C.M., Andreu, D., Boman, H.G., and Merrifield, R.B. (1990) All-D amino acid-containing channel-forming antibiotic peptides. Proc. Natl Acad. Sci. USA 87, 4761-4765
22. Darveau, R.P., Cunningham, M.D., Seachord, C.L., Cassiano-Clough, L., Cosand, W.L., Blake, J., and Watkins, C.S. (1991) Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob. Agents Chemother. 35, 1153-1159
23. Oren, Z., Hong, J., and Shai, Y. (1997) A repertoire of novel antibacterial diastereomeric peptides with selective cytolytic activity. J. Biol. Chem. 272, 14643-14649
24. Yeaman, M.R., Gank, K.D., Bayer, A.S., and Brass, E.P. (2002) Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob. Agents Chemother. 46, 3883-3891
25. Papo, N., Oren, Z., Pag, U., Sahl, H.G., and Shai, Y. (2002) The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J. Biol. Chem. 277, 33913-33921
26. Braunstein, A., Papo, N., and Shai, Y. (2004) In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria. Antimicrob. Agents Chemother. 48, 3127-3129
27. Yan, H., Li, S., Sun, X., Mi, H., and He, B. (2003) Individual substitution analogs of Mel(12-26), melittin. FEBS Lett. 554, 100-104
28. Sun, X., Chen, S., Li, S., Yan, H., Fan, Y., and Mi, H. (2005) Deletion of two C-terminal Gln residues of 12-26-residue fragment of melittin improves its antimicrobial activity. Peptides 26, 369-375
29. Kastantin, M., Ananthanarayanan, B., Lin, B., Ressl, J., Black, M., and Tirrell, M. (2007) Increase of fluorescence anisotropy upon self-assembly in headgroup-labeled surfactants. Macromol. Biosci. 7, 189-194
30. Powell, M.F., Grey, H., Gaeta, F.C.A., Sette, A., and Colon, S.M. (1992) Peptide stability in drug development: a comparison of peptide reactivity in different biological media. J. Pharm. Sci. 81, 731-735
31. Hoffmann, R., Bulet, P., Urge, L., and Otvos, L. Jr. (1999) Range of activity and metabolic stability of synthetic antibacterial glycopeptides from insects. Biochim. Biophys. Acta 1426, 459-467
32. Fredholt, K., Adrian, C., Just, L., Larsen, D.H., Weng, S., Mossc, B., and Friis, J.G. (2000) Chemical and enzymatic stability as well as transport properties of a Leu-enkephalin analogue and ester prodrugs thereof. J. Control. Release 63, 261-273
33. Panyutich, A.V., Szold, O., Poon, P.H., Tseng, Y., and Ganz, T. (1994) Identification of defensin binding to Cl complement. FEBS Lett. 356, 169-173
34. Kopecky, E.-M., Greinstetter, S., Pabinger, I., Buchacher, A., Römisch, J., and Jungbauer, A. (2006) Effect of oriented or random PEGylation on bioactivity of a factor VIII inhibitor blocking peptide. Biotechnol. Bioeng. 93, 647-655
35. Pan, C.Q., Li, F., Tom, I., Wang, W., Dumas, M., Froland, W., Yung, S.L., Li, Y., Roczniak, S., Claus, T.H., Wang, Y.J., and Whelan, J.P. (2007) Engineering novel VPAC2 selective agonists with improved stability and glucose lowering activity in vivo. J. Pharmacol. Exp. Ther. 320, 900-906
36. Imura, Y., Nishida, M., Ogawa, Y., Takakura, Y., and Matsuzaki, K. (2004) Effects of PEGylation on the activity of tachyplesin I. J. Pharm. Soc. Jap. 124 (Suppl. 4), 117-120
37. Harris, J.M., and Kozlowski, A. (1997) Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications. US Patent No. 5672662.
38. Chen, Y.J., Yang, J.T., and Martinez, H.M. (1992) Determination of the secondary structures of proteins by circular dichroism and optical rotatory dispersiont. Biochemistry 11, 4120-4131
39. Kim, J.-H., Domach, M.M., and Tilton, R.D. (1999) Pyrene micropartitioning and solubilization by sodium dodecyl sulfate complexes with poly(ethylene glycol). J. Phys. Chem. B 103, 10582-10590
40. Imura, Y., Nishida, M., and Matsuzaki, K. (2007) Action mechanism of PEGylated magainin 2 analogue peptide. Biochim. Biophys. Acta 1768, 2578-2585